~~<i id='833BF57650'><strike id='833BF57650'><tt id='833BF57650'><pre id='833BF57650'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：knowledge 2025-09-05 09:11:13 - browse：165

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： What affirmative action's end means to a medical student

focus

knowledge

Wikipedia

focus

explore

AdobeHundredsofgeneticvariantscannudgesomeone’sriskofbreastcancerupordownortowardsaparticularsubtype

WSS

Biogen joins immunology wave with $1.15 billion acquisition of HI

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Reports of telehealth's death have been greatly exaggerated

What affirmative action's end means to a medical student

Making the case for fair compensation in clinical trials

What affirmative action's end means to a medical student

focus

leisure time

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Supreme Court strikes down use of affirmative action

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

As demand for Covid shots wanes, Moderna seeks its next success

Canadians with cystic fibrosis outlive Americans by a decade

Medical leaders decry Supreme Court decision on affirmative action

How Robert F. Kennedy Jr. distorted vaccine science

Virginia high school admissions case could be legal follow

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

knowledge

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Prescription digital therapeutics are key to pharma’s future

Cue Health, Covid

Crowdfunding for unproven stem cell procedures spreads misinformation

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Wikipedia

focus

focus

explore